Abstract: STUDY DESIGN: Retrospective analysis of data from patients participating in the Lumbar Spinal Stenosis Outcome Study (LSOS). OBJECTIVE: The aim of LSOS was to assess clinical outcomes after surgical or nonoperative treatment in patients with and without prior epidural steroid injections. SUMMARY OF BACKGROUND DATA: Epidural steroid injections (ESI), a common treatment modality, reduce symptoms in the short-term, but according to a subgroup analysis from the Spine Patient Outcomes Research Trial (SPORT) they reduce the amount of improvement after subsequent surgical or nonoperative treatment. METHODS: The data of 281 patients with lumbar spinal stenosis who had completed baseline and 6-month follow-up assessments were analyzed. Patients completed the Spinal Stenosis Measure (SSM). Changes in the SSM scores from baseline to follow-up were compared between patients with and without prior ESI, for the surgical and nonsurgical treatment groups. RESULTS: The mean (SD) age of the patients was 75 (8.7) years. 229 patients underwent surgery and 111 of these had received an ESI in the 12 months before surgery. Of the 52 patients treated nonoperatively, 29 had received a prior ESI. The unadjusted changes (improvement) in the SSM-symptom scores between baseline and 6 months' follow up were: surgery and prior ESI 0.95, surgery and no prior ESI 0.78 (P = 0.15); no surgery and prior ESI 0.28, no surgery and no prior ESI 0.29 (P = 0.85). When adjusted for confounding factors, the reduction in SSM-symptom score was greater for surgery than for nonoperative treatment by 0.41 points (P < 0.001); the effect of having had an ESI prior to study entry was -0.08 (P = 0.40). CONCLUSION: The analysis of outcomes in the LSOS cohort provided no evidence that ESIs have a negative effect on the short-term outcome of surgery or nonoperative treatment in patients with lumbar spinal stenosis. LEVEL OF EVIDENCE: 3. 
P
atients with lumbar spinal stenosis and neurogenic claudication can be offered 3 different treatment modalities with increasing invasiveness: nonoperative treatment with physical exercise and/or analgesics, epidural injections of steroids and/or analgesics, and surgical decompression with or without fusion. 1 Although the effi cacy of epidural steroid injections (ESIs) in patients with lumbar stenosis is still a matter of debate, the number of injections in such patients tripled in the Medicare population from 1994 to 2001. 2 Some trial results indicate a short-term benefi t of ESIs in patients with lumbar spinal stenosis, [3] [4] [5] [6] [7] but the majority of the studies evaluating the longer-term effi cacy (6 mo to 2 yr) show no clinically relevant improvement compared with physical therapy 1 and the Guideline of the "North American Spine Society" recommends ESIs with some reluctance in patients with lumbar stenosis. 8 , 9 Done in the correct manner, under contrast-enhanced fl uoroscopy, or CT-guided, ESIs are considered safe. The complication rate, including infection and bleeding, is very low. However, a recent study evaluating clinical outcome after ESIs reported disquieting results: those patients treated with ESIs were less likely to benefi t from subsequent surgical or nonoperative treatment compared with patients who had not received ESIs. 10 In both groups of patients, treated surgically or nonoperatively, pain and physical function were worse in the subsequent 4-year follow-up period in patients who had undergone ESIs in the 3 months prior to treatment. This result was unexpected, and the study was criticized for various reasons, 11 , 12 including the failure to use a conditionspecifi c instrument such as the Spinal Stenosis Measure (SSM) as the primary outcome measure. Further studies were recommended in order to establish whether the fi ndings could be reproduced.
The aim of this study is to report the clinical outcome after surgical or nonoperative treatment in patients participating in the Lumbar Spinal Stenosis Outcome Study (LSOS) 13 who either did or did not receive an ESI within the 12 months prior to enrollment.
PATIENTS AND METHODS
The LSOS working group was established in Switzerland in 2009, to perform a multicenter observational study evaluating the treatment and prognosis of patients with lumbar spinal stenosis. 13 This substudy is part of the LSOS. The study was approved by the local ethical committee and conducted in accordance with the Declaration of Helsinki.
14 All patients received written and oral information about the study and gave their written informed consent to participate.
Eligibility Criteria and Patients
The inclusion criteria were: (1) aged 50 years or more; (2) uni-or bilateral neurogenic claudication (defi ned by pain in the buttocks and/or lower extremities provoked by walking or extended standing and relieved by rest and/ or bending forward; (3) verifi ed diagnosis of spinal stenosis by Magnetic Resonance Imaging (MRI) or Computer tomography (CT); (4) expected life expectancy of more than 1 year; (5) able to give informed consent; (6) available for follow-up and able to complete questionnaires in the German language. The exclusion criteria were: (1) cauda equina syndrome requiring urgent surgery; (2) current fracture, infection, or signifi cant deformity ( > 15 ° lumbar scoliosis); (3) current enrolment in another spine related treatment study; (4) clinically relevant peripheral arterial disease (confi rmed by vascular specialist in patients without palpable pulses in the lower limb).
For the assessment of a potentially harmful effect of ESIs-i.e., less improvement after surgical or nonoperative treatment-all patients in the LSOS cohort with a 6-month follow-up were identifi ed. These patients were included and allocated to 1 of 4 groups: (1) Patients who had undergone surgery (decompression, with or without fusion) between baseline and 6 months' follow-up, and with ESI in the 12 months before surgery; (2) Patients who had undergone surgery between baseline and 6 months' follow-up, without any prior ESI; (3) Patients treated nonoperatively (physical therapy and/or oral analgesics, but no epidural injections) between baseline and 6 months' follow-up, with ESI in the 12 months before inclusion in the study; (4) Patients treated nonoperatively (physical therapy and/or oral analgesics) between baseline and 6 months' follow-up, without any prior ESI.
Data Collection
Demographic data, and information about the duration of symptoms and epidural injections in the past were collected at baseline. At baseline and 6 months' follow-up, the following patient-oriented questionnaires (German language versions) were used to gather information about the patients' complaints:
1. the SSM, a disease specifi c questionnaire 15 , 16 with 3 subscales assessing the severity of symptoms (SSM symptom severity scale), physical function (SSM physical function), and satisfaction with treatment results (SSM satisfaction). The SSM symptom severity scale comprises a pain subdomain and a neuroischemic subdomain. Each item is rated on a Likert scale. Response options on the SSM symptom severity scale range from "no symptoms" [1] to "very severe symptoms" [5] ; on the SSM function scale, from "yes, comfortably" [1] to "no, could not perform" [5] , and on the SSM satisfaction scale, from "very satisfi ed" [1] to "very dissatisfi ed" [4] 21 6. Chronic Illness Rating Scale for the measurement of comorbidities (sum score 0-56; higher values indicate a higher number of and/or more severe comorbidities) 22 In addition, detailed information was recorded about treatments received between baseline and 6 months' follow-up.
Imaging Procedures
MRI of the lumbar spine was carried out at baseline, if not already done in the 3 months prior to inclusion in the study. In patients with contraindications to MRI, computer tomography was performed. Board-certifi ed, experienced radiologists evaluated images from all patients and confi rmed the presence of radiological lumbar spinal stenosis.
Data Analysis
All data were collected on paper forms and were entered independently by 2 persons into a Filemaker database (FileMaker Inc.) and checked for inconsistencies. Descriptive statistics are presented as means and standard deviations for continuous variables and as numbers and percentages of total for categorical variables. The primary analyses comprised comparisons of the change in the SSM score and its subscale scores from baseline to 6 months' follow-up between those with and without previous epidural steroid injections, for each of the 2 treatment groups (surgical and nonsurgical treatment). In addition, changes in the SSM scores between baseline and 6 months' follow-up were compared between patients with 1 or more than 1 previous epidural steroid injections, for each of the 2 treatment groups. The Wilcoxon rank sum test was used to evaluate raw differences between the groups.
Additionally, multiple linear regression models were fi tted separately to the 4 SSM subscales Function, Symptoms, Pain Domain, and Neuroischemic Pain at 6 months. The independent variables were surgical treatment (yes/no) and epidural steroid injection prior to baseline (yes/no). Additionally, the respective SSM subscale baseline score, age, gender, HADS score anxiety, HADS score depression, pain duration more than 6 months, and the CIRS comorbidity score were included in the regression model to adjust for potential confounding. We also included an interaction term between surgical treatment and ESI, to determine whether any effect of ESI might differ between the treatment groups. If the P -value for the interaction effect was 0.05 or more, the interaction term was removed from the model. P -values less than 0.05 were considered statistically signifi cant. All analyses were conducted with R for Windows (R Core Team (2014). R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. URL http://www.R-project.org/ .)
RESULTS
By June 1, 2014, 415 patients were enrolled in the study. Data at baseline and 6 months' follow-up were available for 369 patients in the LSOS ( Figure 1 ). Of these, 88 had received 1 or more ESIs between baseline and 6 months' follow up and were excluded from further analyses. For 46 patients, no data were available for the 6-month follow-up. The remaining 281 were included in the present study. A total of 229 patients had undergone surgery between baseline and 6 months' follow-up: 111 of these had received an ESI in the 12 months prior to surgery and 118 had not. 52 patients were treated nonoperatively: 29 had received an ESI in the 12 months before study entry and 23 had not. The exact number of ESIs received by the patients in the previous 12 months are shown in Table 1 .
The patients' demographic details and other baseline data are shown in Table 2 . The mean age of the patients was 75 (SD 8.7) years. In the nonoperative treatment arm, 60% were female, and in the surgical group, 50%. In about (2/3) of the patients, symptoms of lumbar spinal stenosis had been present for more than 1 year and in about 10%, less than 3 months. More than 80% of the patients were retired.
The surgical interventions comprised posterior lumbar decompression (with the specifi c technique being dependent on the surgeon's preference and including bilateral (hemi) laminotomy through a unilateral approach, interlaminar laminotomy, or laminectomy), with or without additional fusion, depending on the surgeon's assessment of the individual pathology ( Table 3 ). In the group with prior ESI, 3 patients were reoperated between baseline and 6 months' follow-up; in the group with no prior ESI, 4 patients were reoperated.
Mean baseline scores for all subdomains of the SSM were higher in patients undergoing surgery compared with patients in the nonoperative treatment group ( Table 4 ). The same was true for leg pain and Roland Morris disability scores ( Quality of life at baseline, quantifi ed by the EQ-5D questionnaire, was lower in the group undergoing surgery ( Table 5 ) . At 6 months' follow-up, improvements in unadjusted SSM scores, Roland Morris and EQ-5D were more pronounced in the surgical group compared with the nonoperative group ( Tables 4 and 5 ) .
Changes in the unadjusted SSM scores between baseline and 6 months' follow-up were not statistically signifi cantly different between patients with and without prior ESI, in either the surgical or nonoperative patient groups ( Table 4 ) . Similarly, changes in the unadjusted SSM scores between patients with 1 previous ESI and patients with more than 1 ESI were not statistically signifi cantly different ( Table 6 ) .
Adjusted mean change scores from baseline in SSM Symptoms, SSM Function, SSM Pain Domain, and SSM Neuroischemic Pain in relation to the treatment modality (surgery yes/no, epidural steroid injection yes/no) are displayed in Figure 2 There was just 1 signifi cant interaction between surgery and ESI prior to study entry, for SSM Function: the interaction effect was − 0.46 ( P = 0.01) (having had an ESI led to less improvement in the nonoperative group but not the surgical group). The change-scores for the NRS, Roland Morris, and EQ-5D followed the same pattern as the SSM, with 2 exceptions: compared with no prior ESI, nonoperative patients who had received a prior ESI showed a reduced quality of life (EQ-5D) and a slight increase of NRS values between baseline and 6 months' follow-up, indicating a worsening of the symptom state ( Table 5 ) .
DISCUSSION
The results of our study indicate that ESIs administered to patients with lumbar spinal stenosis in the year prior to surgery have no relevant impact on the outcome of surgical treatment, as measured by the disease-specifi c SSM. The changes in SSM scores between baseline and 6 months' follow-up were not signifi cantly different between patients with and without prior ESI. At baseline, the SSM scores were higher (indicating more severe symptoms) in the patients undergoing surgery compared with patients treated by nonoperative measures. Improvement after 6 months was more pronounced in the surgically treated group. Similar fi ndings were observed for the other outcome measures-quality of life, leg pain, and disability, except that patients in the nonoperative treatment group with prior ESIs showed a worsening of quality of life and leg pain between baseline and 6 months' follow up. An explanation for the differences in leg pain and quality of life could be the higher proportion of patients with the 2 comorbidities (gonarthritis 28% vs. 10% and heart failure 10% vs. 3%) in the group of patients with prior ESIs, compared with those without.
Radcliff et al 10 reported that ESIs were associated with signifi cantly less improvement during 4 years' follow-up in patients treated either surgically or nonoperatively for lumbar spinal stenosis. In several studies, detrimental complications after epidural steroid injections have been reported, such as infections, bleeding and spinal cord injuries, although the incidence is very low. 
➢ Key Points
ESIs are frequently used in the treatment of patients with lumbar spinal stenosis. A recent publication from the SPORT reported that ESIs had a negative impact on the subsequent outcome of surgery and nonoperative treatment.
The results of the present study did not support those of SPORT and instead suggested no infl uence of prior ESIs on the outcome of surgical or nonoperative treatment for lumbar spinal stenosis.
no negative consequences of ESIs in relation to subsequent treatment outcome had been suspected. Our results do not support the fi ndings of the subgroup analysis in the SPORT, although the patient populations of the 2 studies were slightly different. The SPORT also included patients with radicular pain, 10 whereas our study included only patients with neurogenic claudication. Furthermore, we did not exclude patients with any form of spondylolisthesis per se. We only excluded patients with signifi cant (>15 ° ) scoliosis. Concerns regarding the validity of the conclusions of the SPORT trial, based on objections to some of the methodology, have been raised since its publication. 11 , 12 The number of patients treated with epidural steroid injections has increased enormously in the last 2 decades, although there is ongoing discussion concerning their effi cacy. The authors of a recently published randomized trial concluded that the combination of steroids and lidicocaine, compared with lidocaine only, offered a minimal benefi t after 3 weeks, but not after 6 weeks. 7 In the United States, more than 10 million injections per annum are administered, not only-but to a large extent-in patients with lumbar stenosis. 25 Some insurance companies in the United States reimburse costs for surgery, only when a trial of treatment with epidural steroids has failed. 26 Our study has some limitations. The patients were not assigned randomly, either to surgical or nonoperative treatment, or to ESIs or not. The LSOS is an observational study and the specifi c treatment to be administered was at the discretion of the physicians and their patients. This explains the differences in the SSM scores at baseline between surgical and nonoperative patients, with higher SSM scores in the surgically treated group. In both treatment groups (operative and nonoperative) there were no signifi cant differences between the 2 subgroups-ESI versus no ESI-for the adjusted SSM change scores from baseline to 6 months' follow-up, except for SSM function in the nonoperative group. Patients in the ESI subgroups were similar with respect to age, sex, duration of symptoms, and SSM scores; however, we concede that other potentially relevant prognostic indicators could have been unevenly distributed between the groups, masking real differences in outcome. A second limitation of our study was the shorter follow-up of just 6 months compared with 4 years in the SPORT. However, Radcliff et al 10 reported the differences in outcome at regular time-points during 4-year period, and according to the fi gure in their publication, the negative effect of ESIs on improvement in both the surgical and nonoperative groups was already noticeable after 6 months. A third limitation of the present study is the small number of patients in the nonoperative treatment group, limiting the precision of the results and potentially leading to a type II error (failure to reject a false null hypothesis).
The results of our study do not support the conclusion of the subanalysis of the SPORT. The analysis of outcomes after 6 months in the LSOS cohort provides no evidence that ESIs have a negative effect on the short-term outcome after surgery or nonoperative treatment in patients with lumbar spinal stenosis. 
ACKNOWLEDGMENTS

